← Back to search
ADVANCED ACCELERATOR APPLICATIONS USA INC
NEW YORK, NY, 10118
Unclaimed
Prime contracting experience
Showing the 50 most recent of 53 records from government sources. Past participation is not evidence of current teaming interest.
| Role | Agency | Description | Vehicle | Obligated | Action date | Period |
|---|---|---|---|---|---|---|
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO? (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN) | 36F79719D0169USAspending | $1,063,332 | Sep 23, 2026 | Oct 1, 2024 – Sep 30, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | VISN PADIOPHARMACEUTICAL PLUVICTO DRUG | 36C24925A0031USAspending | $891,651 | Sep 14, 2026 | Dec 20, 2025 – Dec 19, 2026 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN) | 36F79719D0169USAspending | $422,010 | Jul 8, 2026 | Oct 1, 2023 – Feb 28, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO RADIOPHARM | 36F79719D0169USAspending | $1,095,121 | Jun 26, 2026 | Nov 1, 2024 – Oct 31, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO PROSTATE CANCER TREATMENT | 36F79719D0169USAspending | $1,819,183 | May 1, 2026 | Oct 1, 2023 – Sep 30, 2024 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | VA PHOENIX PLUVICTO | 36F79719D0169USAspending | $664,583 | Apr 16, 2026 | Jan 1, 2025 – Dec 31, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO PROSTATE CANCER THERAPY VANCHCS | 36F79719D0169USAspending | $1,693,772 | Apr 9, 2026 | Oct 1, 2024 – Sep 30, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO AND LUTATHERA FY 25 | 36F79719D0169USAspending | $3,485,014 | Mar 23, 2026 | Nov 1, 2024 – Oct 31, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO AND LUTATHERA | 36C25523A0004USAspending | $1,362,395 | Feb 25, 2026 | Feb 17, 2025 – Feb 15, 2026 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO AND LUTATHERA | 36C25523A0004USAspending | $1,200,000 | Jan 13, 2026 | Feb 17, 2026 – Feb 16, 2027 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | LUTETIUM - PLUVICTO AND LUTATHERA | 36F79719D0169USAspending | $2,850,695 | Dec 22, 2025 | Jan 1, 2025 – Dec 31, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | RADIOPHARMACEUTICALS: LUTETIUM LU 177 PLUVICTO 27MCI/ML. | 36C26025A0008USAspending | $996,874 | Dec 19, 2025 | Jan 1, 2026 – Dec 31, 2026 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO | 36C25023A0020USAspending | $896,106 | Nov 24, 2025 | Oct 1, 2024 – Sep 30, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PURCHASE OF MEDICATION ON AN 'AS-NEEDED' BASIS FOR 8 MONTHS. | 36F79719D0169USAspending | $631,354 | Nov 12, 2025 | Jan 1, 2025 – Aug 31, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO (LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN) | 36C25524A0025USAspending | $429,198 | Oct 21, 2025 | Apr 4, 2024 – Mar 27, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO | 36C24223A0022USAspending | $616,784 | Oct 17, 2025 | Feb 1, 2024 – Sep 30, 2024 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO DO/TO | 36F79719D0169USAspending | $298,822 | Aug 20, 2025 | Oct 28, 2024 – Jan 30, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO AND LUTATHERA | 36C25523A0004USAspending | $1,140,422 | Aug 6, 2025 | Feb 17, 2024 – Feb 16, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | 5 YR LUTATHERA DELIVERY ORDER FOR SAN FRANCISCO VAMC | 36F79719D0169USAspending | $884,033 | Aug 1, 2025 | Nov 17, 2021 – Sep 30, 2026 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | LUTETIUM (LU177) DOTATATE: QTY 20 LUTETIUM (LU177) PSMA: QTY 100 | 36F79719D0169USAspending | $2,380,078 | Jul 9, 2025 | Feb 6, 2024 – Feb 5, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | LUTATHERA (LU-177 DOTATATE RADIOPHARMACEUTICAL) | 36F79719D0169USAspending | $925,207 | Jun 13, 2025 | Jan 28, 2022 – Feb 3, 2023 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | LU-177 LUTATHERA DOTATATE | 36F79719D0169USAspending | $586,709 | Apr 17, 2025 | Dec 13, 2021 – Sep 30, 2024 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO RADIOPHARM | 36F79719D0169USAspending | $714,171 | Apr 8, 2025 | Jun 26, 2024 – Dec 31, 2024 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | LUTATHERA (LUTETIUM LU 177 DOTATATE) | 36F79719D0169USAspending | $679,949 | Mar 26, 2025 | Oct 1, 2024 – Sep 30, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO | 36F79719D0169USAspending | $4,659,068 | Mar 18, 2025 | Oct 15, 2023 – Oct 31, 2024 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO AND LUTATHERA | 36F79719D0169USAspending | $2,356,914 | Mar 3, 2025 | Jan 1, 2024 – Dec 31, 2024 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO BPA CALL CY24 DOSES | 36C25223A0017USAspending | $977,750 | Feb 24, 2025 | Jan 2, 2024 – Dec 31, 2024 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO | 36C25023A0020USAspending | $975,163 | Dec 5, 2024 | Oct 1, 2023 – Sep 30, 2024 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO PROSTATE CANCER THERAPY | 36F79719D0169USAspending | $2,110,050 | Dec 5, 2024 | Jul 26, 2023 – Sep 30, 2024 |
| Prime | Department of Defense Defense Health Agency | SIX BRANDED NUCLEAR MEDICINE FDA APPROVED LUTATHERA AND PLUVICTO. | — | $498,438 | Dec 4, 2024 | Dec 4, 2024 – Dec 4, 2025 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | LUTETIUM LUTATHERA & PLUVICTO FOR 1 YEAR | 36F79719D0169USAspending | $1,956,065 | Oct 21, 2024 | Jan 1, 2023 – Dec 31, 2023 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO AND LUTATHERA RADIOPHARMACEUTICALS | 36C25523A0006USAspending | $486,935 | Sep 9, 2024 | Dec 1, 2022 – Nov 30, 2023 |
| Prime | Department of Defense Department of the Army | PLUVICTO (LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN) AND LUTATHERA (LUTETIUM LU-177 DOTATATE) | — | $2,570,634 | Jul 25, 2024 | Oct 1, 2023 – Sep 30, 2024 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO AND LUTATHERA | 36C25523A0004USAspending | $779,095 | Jun 7, 2024 | Apr 6, 2023 – Feb 16, 2024 |
| Prime | Department of Defense Defense Health Agency | PLUVICTO LUTETIUM LU177 VIPIVOTIDE TETRA | — | $481,665 | Apr 26, 2024 | Apr 26, 2024 – May 3, 2024 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | RADIOPHARMACEUTICALS | 36F79719D0169USAspending | $2,476,989 | Apr 24, 2024 | Feb 4, 2023 – Feb 3, 2024 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO RADIOPHARMACEUTICAL DOSES MAR-DEC 2023 | 36C25223A0017USAspending | $389,548 | Mar 27, 2024 | Mar 30, 2023 – Dec 31, 2023 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO RADIOPHARMACEUTICALS | 36F79719D0169USAspending | $649,246 | Nov 28, 2023 | Dec 1, 2023 – Nov 30, 2024 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO | 36F79719D0169USAspending | $2,207,437 | Oct 12, 2023 | Mar 16, 2023 – Mar 15, 2024 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | LUTATHERA (LUTETIUM LU 177 DOTATATE) | 36F79719D0169USAspending | $646,116 | Oct 5, 2023 | Oct 1, 2023 – Sep 30, 2024 |
| Prime | Department of Defense Defense Health Agency | NUCLEAR MEDICINE FDA APPROVED LUTATHERA. | — | $468,068 | Sep 29, 2023 | Sep 30, 2023 – Dec 29, 2023 |
| Prime | Department of Defense Department of the Army | LUTETIUM LU-177VIPIVOTIDE TETRAXETAN | — | $1,457,062 | Sep 11, 2023 | Oct 1, 2022 – Oct 1, 2022 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO PROSTATE CANCER TREATMENT (NDC: 69488-0010-61) | 36F79719D0169USAspending | $3,668,241 | Aug 8, 2023 | Sep 12, 2022 – Sep 30, 2023 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | RADIOPHARM | 36F79719D0169USAspending | $349,600 | Jun 22, 2023 | Jan 26, 2021 – Jan 25, 2022 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO | 36F79719D0169USAspending | $876,482 | Apr 18, 2023 | Oct 1, 2022 – Mar 15, 2023 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | RADIO PHARMACEUTICALS | — | $323,100 | Feb 7, 2023 | Jul 1, 2018 – Jun 30, 2019 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | GALLIUM GA 68 DOTATATE ISOTOPES (NETSPOT) | — | $398,400 | Jan 25, 2023 | Jan 10, 2019 – Sep 30, 2022 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | LUTETIUM | 36F79719D0169USAspending | $435,606 | Oct 27, 2022 | Oct 1, 2022 – Dec 31, 2022 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | PLUVICTO FOR PATIENT AT VAGLAHCS FROM 08/01/2022 - 09/30/2022 | 36F79719D0169USAspending | $292,161 | Aug 1, 2022 | Aug 1, 2022 – Sep 30, 2022 |
| Prime | Department of Veterans Affairs Department of Veterans Affairs | LU177 DOTATATE | 36F79719D0169USAspending | $376,285 | Jun 21, 2022 | Jan 13, 2021 – Jan 12, 2022 |
Contract vehicles are shown only when present in the source record. Linked award numbers and vehicles open the authoritative record on USAspending.gov.
Agencies supported
- Department of Veterans AffairsGov-sourced
- Department of DefenseGov-sourced